-
DMD Trial Supports ATL1102’s Safety in Improving Muscle Strength
A Phase 2 clinical trial of ATL1102 met its primary goal of demonstrating favorable safety and tolerability in boys with Duchenne muscular dystrophy. Read more about it here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.